{
    "Trade/Device Name(s)": [
        "Quantia IgE",
        "Quantia Ferritin/Myoglobin/IgE Control",
        "Quantia IgE Standard"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K050493",
    "Predicate Device Reference 510(k) Number(s)": [
        "K964152",
        "K040879",
        "K042982"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DGC",
        "JJX",
        "JJS"
    ],
    "Summary Letter Date": "August 16, 2005",
    "Summary Letter Received Date": "March 1, 2005",
    "Submission Date": "February 24, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A,G,M,D,E Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "allergy"
    ],
    "Analyte(s)": [
        "Immunoglobulin E"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AEROSET System",
        "Abbott AEROSET"
    ],
    "Method(s)/Technology(ies)": [
        "Latex particle enhanced immunoturbidimetric assay",
        "Turbidimetry"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Standard"
    ],
    "Document Summary": "FDA 510(k) summary for Quantia IgE immunoturbidimetric assay and associated controls/standards for quantitative determination of IgE in human serum or plasma",
    "Indications for Use Summary": "For in vitro quantitative determination of Immunoglobulin E concentration in human serum or plasma using immunoturbidimetry, and for monitoring quality control and calibration of assay results",
    "fda_folder": "Immunology"
}